NightOwl, an FDA-cleared home sleep apnea test (HSAT) offers a simplified, accurate, efficient way to diagnose obstructive sleep apnea (OSA). It adds another offering to Resmed’s portfolio, which is led by the company’s continuous positive airway pressure (CPAP) systems for treating OSA.
San Dieog-based Resmed says NightOwl makes it easy to detect OSA. The small sensor worn on the fingertip aligns with simple, easy-to-use digital platforms for individuals and providers.
A disposable device, NightOwl records up to 10 nights of sleep data for a single patient. It captures night-to-night variability and provides clinicians with a comprehensive view of an individual’s sleep patterns. The device sends sleep data remotely to a cloud-based diagnostic platform for physician analysis and review.
Resmed says NightOwl enables quick interpretation, streamlines workflows and helps deliver more timely diagnoses. Additional features include auto-scored results, seamless integration with Somnoware software and pairing with the Resmed myAir app.
“Now more than ever, people want healthcare experiences that are easy, convenient, and accessible, however, navigating sleep apnea testing can be complex,” said Dr. Carlos M. Nunez, chief medical officer at Resmed. “With NightOwl, people can easily complete a sleep apnea test from the comfort of home using just a fingertip sensor and a smartphone. It also simplifies the process for providers. This is a meaningful step forward in Resmed’s mission to deliver life-changing health technology that people love.”
